Picture of Gossamer Bio logo

GOSS — Gossamer Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Gossamer Bio Announces Second Quarter 2022 Financial Results And Provides Business Update

Aug 9 (Reuters) - Gossamer Bio Inc  GOSS.O :
    * GOSSAMER BIO ANNOUNCES SECOND QUARTER 2022 FINANCIAL RESULTS AND PROVIDES
BUSINESS UPDATE
    * $342 MILLION IN CASH, CASH EQUIVALENTS & MARKETABLE SECURITIES, AS OF JUNE
30,
2022
    * GOSSAMER BIO - EXPECTS COMBINATION OF CURRENT CASH, CASH EQUIVALENTS
SUFFICIENT
TO FUND ITS OPERATING AND CAPITAL EXPENDITURES INTO Q2 OF 2024
    * NET LOSS FOR QUARTER ENDED JUNE 30, 2022, WAS $56.5 MILLION, OR $0.74 PER
SHARE
    * Q2 EARNINGS PER SHARE VIEW $-0.70 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nBw5pTQlfa 
Further company coverage:  GOSS.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Gossamer Bio

See all news